Back to search

Article

SAMHD1 controls nucleoside-based cancer therapeutics, deoxyguanosine toxicity, and inflammation

2022-08-27

Abstract excerpt

<h4>ABSTRACT</h4> SAMHD1 is a key regulator of dNTP metabolism, being activated by dGTP and converting dNTPs into their respective nucleosides. As a result, it plays a significant role in several distinct diseases. Not only is SAMHD1 a restriction factor for HIV-1 replication, which requires dNTPs for replication, but it is also required for genome stability, is mutated in multiple cancers, and loss of function m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
51237642-2505-5d17-b6ad-e2d749547ebf
DOI
10.1101/2022.08.25.505278
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SAMHD1 controls nucleoside-based cancer therapeutics, deoxyguanosine toxicity, and inflammationDOI 10.1101/2022.08.25.505278
Select a neighboring publication to make it the new centre.